(Press-News.org) A multi-institutional study from the Accelerating GBM Therapies Through Serial Biopsies TeamLab, led by investigators from the Mass General Brigham Cancer Institute, found that serially testing tumor samples can help detect when a cancer treatment is activating the immune system in recurrent glioblastoma (GBM), even when traditional imaging measures cannot. Their results are published in Science Translational Medicine.
GBM is the most aggressive type of brain cancer, known for growing and spreading quickly. It is challenging to treat and almost always comes back. But it can be hard to understand what's happening inside the tumor during treatment.
“Getting tissue from GBM patients is difficult because the brain is sensitive, the procedures are risky, and the tumors themselves are complex and change over time,” said E. Antonio Chiocca, MD, PhD, executive director of the Center for Tumors of the Nervous System at the Mass General Brigham Cancer Institute. “But studying the cancerous tissue itself is also the best way to understand how the tumor reacts to treatment.”
The study involved over 100 brain tumor scientists and clinicians from multiple hospitals, cancer institutes and universities across the United States and was conducted through a multi-institutional collaboration funded by Break Through Cancer. In the study, researchers collected 96 samples over four months from two patients with recurrent GBM in a clinical trial of a new immunotherapy, CAN-3110, which is a form of immunotherapy known as an oncolytic virus, specially engineered to selectively infect and kill tumor cells.
“Standard practice is to not serially sample a patient’s brain tumor as they undergo treatment but instead to take a sample only once before a treatment and then follow a patient’s response using MRI,” said Chiocca. “But this study’s findings suggest that this thinking and practice may need to change to revolutionize how patients can monitor their disease.”
The researchers used multi-omic analysis with data integration supported by Break Through Cancer’s Data Science Hub (DASH). They integrated data from many sources — genetic material, peptides in and around the tumor, metabolites, immune changes and protein signaling factors, and AI-enabled digital pathology, among others.
The serial samples showed that, over time, the drug changed the environment inside and around the tumor, even though the tumor appeared to be progressing on magnetic resonance imaging (MRI) scans. This may happen because the immune system causes swelling and inflammation, which can look like new or enlarging areas of contrast on a scan even when a tumor hasn’t grown, a phenomenon known as pseudoprogression.
If CAN-3110 therapy can reshape the microenvironment and activate the immune system, it may improve patient outcomes, according to the researchers. Of the two patients treated during the study, one showed evidence that the tumor was responding to therapy, while the other’s disease remained stable.
“The breadth and depth of data we generated from repeated tumor biopsies really underscore the value of this approach for studying how therapies work," said Chiocca, who emphasized the collaborative work of the entire team of brain specialists from across the country. "These results give us strong reason to adopt a new paradigm in GBM drug development — one that builds longitudinal sampling into clinical trials to capture real-time snapshots of how tumors respond to treatment over time. Although we reported results on just the first two patients from this trial, we are accruing 12 patients to further solidify our findings. We plan to adopt this clinical trial platform now for two additional and distinct vaccine immunotherapies.
Authorship: In addition to Chiocca, authors include Alexander L. Ling, Jennifer Gantchev, Michael C. Prabhu, Sreyashi Basu, Ryuhjin Ahn, Alicia D’Souza, Nafisa Masud, Anna Ball, Odysseas Nikas, Genaro R. Villa, Michael S. Regan, Gerard Baquer, Georges Ayoub, Charles A. Whittaker, Zaki Abou-Mrad, Andres Santos, Charles P. Couturier, Dina Elharouni, Jayne Vogelzang, Kenny K.H. Yu, Hong Chen, Zhong He, Wen Jiang, Calixto Hope Lucas, Haley E. Sax, Frederick F. Lang, Vinay K. Puduvalli, Viviane Tabar, Cameron Brennan, Adrienne Boire, Matthias Holdhoff, Chetan Bettegowda, Michael Cima, Isaac H. Solomon, Ying Yuan, Paul P. Tak, Padmanee Sharma, Forest M. White, Keith L. Ligon, Nathalie Y.R. Agar, David A. Reardon, and Giacomo Oliveira.
In addition to the authors, the following Accelerating GBM Therapies Through Serial Biopsies TeamLab members have contributed to conceptualization of the study, development of the methodology, clinical trial investigation, and conducting of the analysis: Jennifer Wiley, Kathryn Partridge, Rameen Beroukhim, Amanda Spearman, Ugonma N. Chukwueke, Patrick Y. Wen, Austin L.H. Chiocca, Sarah Frisken, Brian J. Coyne, Daniel Triggs, Kimberly L. Vasquez, Michal O. Nowicki, Himanshu Soni, Raziye Piranlioglu, Marco Mineo, Ana Montalvo Landivar, Sylwia A. Stopka, Md Amin Hossain, Seth W. Malinowski, Sonam Bhatia, Thomas Quinn, Marla J. Polk, Alexsandra B. Espejo, Jingjing Sun, Yulong Chen, Sonali Jindal, Jason T. Huse, Lisa Norberg, Sangeeta Goswami, Betty Y. Kim, Kadir C. Akdemir, Brittany Parker Kerrigan, Douglas Nielsen, Jian Hu, Pratibha Sharma, Chetna Wathoo, Gregory Buchold, Jiyong Liang, Stuart Levine, Qun Cao, Alexei Stortchevoi, Shahiba Ogilvie, Alexandra Giantini Larsen, Kelsey Hopland, Yuval Elhanati, Rachel Estrera, Isaiah Osei-Gyening, Tejus A. Bale, Christopher Douville, Jordina Rincon Torroella, Vasilena Gocheva, Francesca Barone, Jennifer Moliterno
###
About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.
END
Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In the majority of these patients, as the cancer advances it metastasizes to the liver. Despite progress in surgical therapies aimed at eradicating the cancer, many of these patients will have tumor recurrence in the liver.
Now, researchers from UC San Francisco (UCSF), have discovered that a novel combination of immunotherapies can reprogram the immune environment of colon cancer tumors that spread to the liver. In preclinical models, this therapy often eliminated tumors entirely, offering a potential new path for ...
(Santa Barbara, Calif.) — The trade of totoaba has all the intrigue of a crime thriller. Dollars and drugs change hands as a criminal cartel vies against the government. Communities and endangered species are caught in the crosshairs of a lucrative illicit trade. It may then come as a surprise that the totoaba is a fish.
The totoaba is a large, yet unassuming, species of fish native to the Gulf of California. But its mundane appearance belies incredible value on the black market. “Totoaba swimbladder can sell for up to $80,000 USD per kilogram ...
When the Norwegian company that manufactures the Safeback SBX device which is already on the market, approached Eurac Research to have it independently tested, it was clear that the international research team led by physician and researcher Giacomo Strapazzon would publish the results of the study in any case, regardless of the outcome.
For the researchers, the experiment posed a significant challenge, as many participants were completely buried in snow, raising concerns that over two-thirds might require urgent excavation. The volunteer group – composed entirely of enthusiastic ski mountaineers, roughly half of them women – ranged from ...
Acute or short-lived pain, despite its bad reputation, is usually a lifesaver. It acts as a transient negative sensory experience that helps us avoid danger. Touch a hot stove, stub a toe, or bonk your head on a low branch, and the nervous system cues up an “Ow!” Over time, the sting fades, the wound heals, but the lesson sticks.
Chronic pain is different; the alarm keeps blaring long after the fire is out, and then the pain itself becomes the problem. Nearly 50 million people in the United ...
According to a study by researchers at the Universitat Oberta de Catalunya (UOC), time-restricted feeding can have a positive impact on athletes in terms of both their health and performance. The effects of time-restricted eating – where food intake is permitted within a restricted window ranging from 3-4 to 10-12 hours – have been widely studied in the general population, where they have been shown to increase life expectancy, but there is little evidence on its positive effects on high-performance athletes.
The study – "Effect of time-restricted feeding ...
New Curtin University research has found the impact of bushfires and prescribed burns on global bee populations is highly varied, with some species benefiting from fire while others face severe risks.
The study, led by Adjunct Research Fellow Dr Kit Prendergast from Curtin’s School of Molecular and Life Sciences, examined 148 studies from around the world to understand how fire impacts bees.
The review considered the severity, frequency and duration of fires, along with the different characteristics of bees, such as where they ...
Forming sustainable research partnerships with Indigenous peoples requires trust and mutual benefit, say microbiome researchers in an opinion paper publishing October 8 in the Cell Press journal Trends in Microbiology. The paper presents a framework for building this type of relationship based on insights from the team’s 15-year-long collaboration with the Matsés, a group of people who live in the Amazon rainforest on the border of Peru and Brazil. To build trust, the researchers worked in collaboration with the Matsés through all stages of the research project, from developing research methods to disseminating results.
“Establishing genuine partnerships with ...
Engineered polymers hold promise for use in next generation technologies such as light-harvesting devices and implantable electronics that interact with the nervous system – but creating polymers with the right combination of chemical, physical and electronic properties poses a significant challenge. New research offers insights into how polymers can be engineered to fine-tune their electronic properties in order to meet the demands of such specific applications.
“Silicon-based electronics have been around for decades, and we have a thorough understanding of the electronic properties of materials used in those technologies,” says Aram Amassian, co-corresponding author of ...
New research has revealed that about 90 percent of marine aquarium fish sold by online retailers in the United States are sourced directly from wild populations, mostly in the western Pacific and Indian Ocean. With the US accounting for around two-thirds of all global aquarium fish imports, researchers warn that this reliance on wild capture threatens the sustainability of coral reef ecosystems and puts endangered and threatened species at greater risk of extinction.
The research, led by postdoctoral research associate Dr Bing Lin from the University of Sydney’s Thriving Oceans Research Hub in the School of Geosciences, analysed data from four major US-based online aquarium ...
About The Study: Current minimum case volume standards for complex surgical procedures, based on older volume outcome studies, do not align with contemporary practice. These findings demonstrate that volume-outcome curves have changed, with fewer cases needed to meet benchmark 30-day mortality over time.
Corresponding Author: To contact the corresponding author, Nabil Wasif, MD, MPH, email wasif.nabil@mayo.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.17274)
Editor’s Note: Please ...
